Business Impact of Pandemics Such as COVID-19
First written in FY2020. 5 of 10 entries say "Worsened", first in FY2021-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026ReframedAnnual report
「If a new infectious disease emerges, there may be a risk of stagnation in economic activity. This could have a material impact on our group’s performance through supply chain disruptions, stagnant sales representative activity and sluggish consumer spending.」
After COVID-19 subsided, the company reorganised the risk category from a specific infectious disease to “new infectious diseases” in general and stated that it would redevelop its response measures. - FY2024-Q3MitigatedAnnual report
「During the cumulative third-quarter consolidated period, the normalisation of economic activity accelerated following the reclassification of COVID-19, and the economy continued its gradual recovery against a backdrop of improving employment and income conditions and increased inbound demand.」
The company stated that the normalisation of economic activity was accelerating following the reclassification of COVID-19, reducing activity constraints caused by the infectious disease. However, uncertainty remains regarding exchange rates and raw material prices. - FY2024-Q1MitigatedAnnual report
「During the cumulative first-quarter consolidated period, Japan’s economy began to show signs of a gradual recovery as various restrictions on activity were eased following the reclassification of COVID-19.」
The company stated that various restrictions on activity were eased following the reclassification of the infectious disease, reducing constraints on business activity. However, uncertainty remains regarding raw material prices and exchange rate movements. - FY2023MitigatedAnnual report
「Although the COVID-19 infection that had been present is moving toward containment and its risk is declining, if infections spread again, economic activity may once more be restricted. This could have a material impact on our group’s performance through supply chain disruptions, stagnant sales representative activity and sluggish consumer spending.」
The company indicated that the infectious disease is moving toward containment and the risk is declining, while the possibility of an impact on the supply chain, sales representative activity and consumer spending in the event of renewed spread remains. - FY2022WorsenedAnnual report
「If infectious diseases, including COVID-19, spread further, economic activity may be restricted. This could have a material impact on our group’s performance through supply chain disruptions, stagnant sales representative activity and sluggish consumer spending.」
Infectious disease risk continues to be identified as a major risk for the consolidated group as a whole, including the impact on the supply chain, sales representative activity and consumer spending and the difficulty of quantifying the impact on performance. - FY2021WorsenedAnnual report
「If infectious diseases, including COVID-19, spread and take a long time to subside, economic activity may be restricted. This could have a material impact on our group’s performance through supply chain disruptions, stagnant activity by sales representatives, including agents and authorised dealers, and sluggish consumer spending.」
The group’s consolidated risk disclosures describe the continuing impact of infectious diseases on the supply chain, sales representative activity and consumer spending, as well as the difficulty of quantifying the extent of the impact. - FY2021-Q3WorsenedAnnual report
「Against this backdrop, our group implemented a three-year medium-term management plan from April 2019 through the fiscal year ending March 2022 and actively pursued the 2 basic strategies of “revitalizing the Charle business” and “creating a new pillar through new business development.” However, the COVID-19 pandemic has had a substantial impact on product sales and business member activity in the sales business for women’s innerwear and related products. We are considering a review of the medium-term management plan and medium-term management indicators ending in the fiscal year ending March 2022, and plan to disclose the results in April 2021.」
The impact of the infectious disease on sales conditions and business member activity continued, creating a situation that required the medium-term management plan and medium-term management indicators to be reviewed. The company also indicated that disclosure was scheduled for April 2021. - FY2021-Q2WorsenedAnnual report
「However, the business selling women’s innerwear and other products has been significantly affected by COVID-19 in terms of product sales and business member activity, and the company is currently examining the impact on the medium-term management indicators for the final year, the fiscal year ending March 2022.」
The impact of the infectious disease on sales conditions and business member activity continued into the second quarter, and the company began examining its impact on the medium-term management indicators for the fiscal year ending March 2022. - FY2021-Q1WorsenedAnnual report
「In terms of products, sales were significantly affected by delays in product arrivals from overseas business partners caused by the global spread of infection, reduced activity by business members due to requests to refrain from non-essential and non-urgent outings, and weaker consumer sentiment. As a result, during the cumulative first-quarter period, net sales decreased to ¥2,662 million, down 20.8% year on year. Due mainly to the decrease in net sales, operating loss was ¥539 million, compared with an operating loss of ¥102 million in the same quarter of the previous year, ordinary loss was ¥530 million, compared with an ordinary loss of ¥99 million, and quarterly net loss was ¥1,055 million, partly due to the reversal of deferred tax assets, compared with a quarterly net loss of ¥74 million in the same quarter of the previous year.」
The impact of COVID-19 appeared in the business through delayed product arrivals, reduced sales representative activity and weaker consumer sentiment, resulting in a 20.8% decrease in net sales, an operating loss of ¥539 million and a net loss of ¥1,055 million. - FY2020MaterialisedAnnual report
「If various infectious diseases, including COVID-19, spread globally and take a long time to subside, economic activity may be restricted. This could have a material impact on the company’s performance through supply chain disruptions, stagnant sales activity by sales representatives and sluggish consumer spending. Following the government’s declaration of a state of emergency in April 2020, the company implemented measures to minimise these risks, including reminding employees of safety and preventive measures, thoroughly enforcing work-from-home arrangements and travel restrictions, monitoring operating conditions at domestic and overseas production sites and the status of product procurement, disseminating activity guidelines to sales representatives, and providing economic and activity support.」
COVID-19 was first presented as a separate risk item, with the company describing its actual responses, including the declaration of a state of emergency, the suspension of sales activities and event cancellations.